Sandhill Capital Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-127,226
| Closed | -$18M | – | 82 |
|
|
2019
Q3 | $18M | Sell |
127,226
-8,642
| -6% | -$1.23M | 2.2% | 24 |
|
|
2019
Q2 | $17M | Buy |
135,868
+6,957
| +5% | +$871K | 2.16% | 27 |
|
|
2019
Q1 | $14.2M | Buy |
128,911
+6,115
| +5% | +$674K | 1.98% | 28 |
|
|
2018
Q4 | $12M | Buy |
122,796
+2,850
| +2% | +$279K | 1.99% | 25 |
|
|
2018
Q3 | $14.8M | Buy |
119,946
+2,793
| +2% | +$345K | 2.19% | 25 |
|
|
2018
Q2 | $11.6M | Buy |
117,153
+5,564
| +5% | +$552K | 1.84% | 28 |
|
|
2018
Q1 | $9.85M | Buy |
111,589
+7,978
| +8% | +$704K | 1.62% | 29 |
|
|
2017
Q4 | $10.2M | Buy |
103,611
+3,030
| +3% | +$299K | 1.82% | 26 |
|
|
2017
Q3 | $9.68M | Buy |
100,581
+2,776
| +3% | +$267K | 1.89% | 26 |
|
|
2017
Q2 | $9.25M | Buy |
+97,805
| New | +$9.25M | 1.95% | 26 |
|